CIK 0001520262 · Large accelerated filer
Alkermes plc.
Sign in to watch- Ticker
- ALKS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981007018
- Phone
- 00-353-1-772-8000
- Business address
- CONNAUGHT HOUSE, 1 BURLINGTON ROAD, DUBLIN 4, Ireland, 00000
- Former names
- ANTLER SCIENCE TWO PLC, Antler Science Two Ltd
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,070,874
- in 5 filings, $1.1M under 10b5-1 plans
Net −$1,070,874. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-23 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise | +6,407 | 79,173 | ||
| 2024-02-23 | Nichols Christian Todd SVP, Chief Commercial Officer | Shares withheld for taxes | −2,845 | $29.57 | $84K | 76,328 |
| 2024-02-23 | Nichols Christian Todd SVP, Chief Commercial Officer | Option exercise · Restricted Stock Unit Award | −6,407 | 19,223 | ||
| 2024-02-23 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise | +2,283 | 10,948 | ||
| 2024-02-23 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Shares withheld for taxes | −672 | $29.57 | $20K | 10,276 |
| 2024-02-23 | Parisi Samuel Joseph VP, Finance (Interim PAO) | Option exercise · Restricted Stock Unit Award | −2,283 | 6,851 | ||
| 2024-02-23 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise | +5,825 | 118,931 | ||
| 2024-02-23 | Brown Iain Michael SVP, Chief Financial Officer | Shares withheld for taxes | −2,587 | $29.57 | $76K | 116,344 |
| 2024-02-23 | Brown Iain Michael SVP, Chief Financial Officer | Option exercise · Restricted Stock Unit Award | −5,825 | 17,475 | ||
| 2024-02-23 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise | +7,689 | 168,196 | ||
| 2024-02-23 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Shares withheld for taxes | −3,414 | $29.57 | $101K | 164,782 |
| 2024-02-23 | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −7,689 | 23,068 | ||
| 2024-02-23 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise | +4,077 | 283,541 | ||
| 2024-02-23 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Shares withheld for taxes | −1,811 | $29.57 | $54K | 281,730 |
| 2024-02-23 | LANDINE MICHAEL J SVP, Corp Dev., Alkermes, Inc. | Option exercise · Restricted Stock Unit Award | −4,077 | 12,233 | ||
| 2024-02-23 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise | +8,737 | 161,682 | ||
| 2024-02-23 | Jackson Blair Curtis EVP, Chief Operating Officer | Shares withheld for taxes | −3,880 | $29.57 | $115K | 157,802 |
| 2024-02-23 | Jackson Blair Curtis EVP, Chief Operating Officer | Option exercise · Restricted Stock Unit Award | −8,737 | 26,214 | ||
| 2024-02-23 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Option exercise | +7,689 | 113,123 | ||
| 2024-02-23 | Hopkinson Craig C. EVP R&D, Chief Medical Officer | Shares withheld for taxes | −3,414 | $29.57 | $101K | 109,709 |
Page 25 of 41 · 804 trades